Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros

Base de dados
Tipo de documento
País/Região como assunto
Ano de publicação
Intervalo de ano de publicação
1.
Toxins (Basel) ; 5(4): 841-64, 2013 Apr 23.
Artigo em Inglês | MEDLINE | ID: mdl-23612754

RESUMO

The objective of this study was to measure the effects of chronic exposure to fumonisins via the ingestion of feed containing naturally contaminated corn in growing pigs infected or not with Salmonella spp. This exposure to a moderate dietary concentration of fumonisins (11.8 ppm) was sufficient to induce a biological effect in pigs (Sa/So ratio), but no mortality or pathology was observed over 63 days of exposure. No mortality or related clinical signs, even in cases of inoculation with Salmonella (5 × 104 CFU), were observed either. Fumonisins, at these concentrations, did not affect the ability of lymphocytes to proliferate in the presence of mitogens, but after seven days post-inoculation they led to inhibition of the ability of specific Salmonella lymphocytes to proliferate following exposure to a specific Salmonella antigen. However, the ingestion of fumonisins had no impact on Salmonella translocation or seroconversion in inoculated pigs. The inoculation of Salmonella did not affect faecal microbiota profiles, but exposure to moderate concentrations of fumonisins transiently affected the digestive microbiota balance. In cases of co-infection with fumonisins and Salmonella, the microbiota profiles were rapidly and clearly modified as early as 48 h post-Salmonella inoculation. Therefore under these experimental conditions, exposure to an average concentration of fumonisins in naturally contaminated feed had no effect on pig health but did affect the digestive microbiota balance, with Salmonella exposure amplifying this phenomenon.


Assuntos
Contaminação de Alimentos , Fumonisinas/administração & dosagem , Imunidade Celular/efeitos dos fármacos , Intestinos/microbiologia , Salmonella typhimurium/imunologia , Sus scrofa/imunologia , Animais , Animais Endogâmicos , Antígenos de Bactérias/análise , Antígenos de Bactérias/farmacologia , Biomarcadores/sangue , Biomarcadores/metabolismo , Proliferação de Células/efeitos dos fármacos , Fezes/microbiologia , Feminino , França , Fumonisinas/toxicidade , Mucosa Intestinal/metabolismo , Intestinos/imunologia , Linfócitos/efeitos dos fármacos , Linfócitos/imunologia , Masculino , Viabilidade Microbiana/efeitos dos fármacos , Mitógenos/farmacologia , Salmonella typhimurium/efeitos dos fármacos , Salmonella typhimurium/crescimento & desenvolvimento , Salmonella typhimurium/isolamento & purificação , Organismos Livres de Patógenos Específicos , Esfingosina/análogos & derivados , Esfingosina/sangue , Esfingosina/metabolismo , Sus scrofa/crescimento & desenvolvimento , Sus scrofa/metabolismo , Sus scrofa/microbiologia , Aumento de Peso/efeitos dos fármacos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA